Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Incyte Announces Plans to Initiate a Phase 3 Clinical Trial of Ruxolitinib as a Treatment for Patients with COVID-19 Associated Cytokine Storm

      Clinical Trials
      Incyte announced the Company is working with the U.S. FDA to initiate a Phase 3 clinical trial (RUXCOVID) to evaluate the efficacy and safety...

      Mateon Achieves Milestone in its Development of OT-101, a Phase 3 Clinical Drug Candidate, Against COVID-19

      Clinical Trials
      Mateon Therapeutics, Inc dedicated to development OT-101, a TGF-β antisense drug candidate, announced that Mateon has delivered the requisite testing results to Golden Mountain...

      Akers Biosciences and Premas Biotech Announce Progress in its Vaccine Development for Covid-19

      Drug Development
      Akers Biosciences, Inc., a developer of rapid health information technologies, announced that its collaboration with Premas Biotech has successfully completed the milestone of obtaining...

      Digital Science partners with Zhipu.AI to conduct data challenges and build COVID-19 information portal

      Drug Development
      Digital Science, a leading technology company serving emergent needs across the research sector, is pleased to announce a partnership with Beijing-based technology company Zhipu.AI...

      Battelle Develops System to Decontaminate Personal Protective Equipment to Meet Growing Demand During COVID-19 Crisis

      Drug Development
      Battelle announced that it has received Food and Drug Administration (FDA) Emergency Use Authorization (EUA) to support front-line healthcare workers as they face critical...

      WPD, CNS Partner on Drug Development for Coronavirus, Other Antiviral Indications

      Drug Development
      WPD Pharmaceuticals has entered into a development agreement with CNS Pharmaceuticals for the development of several preclinical drug candidates including WP1122, which will be...

      Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research

      Press Statements
      Agilent Technologies Inc. (NYSE: A) introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal research. The new Agilent...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector .....Read More

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.